Claris Ventures Announces First Closing of Claris Biotech II Turin, Italy – December 16th, 2025 – Haptena Therapeutics, a newly formed biotechnology company […]
Claris Ventures Announces First Closing of Claris Biotech II Turin – April 23, 2025 – Claris Ventures today announced the first closing […]
Claris Ventures and Exor Ventures Team Up for the Development of Innovative Drugs in Italy Turin, May 14, 2024 – Claris Ventures […]
CLARIS’S PORTFOLIO COMPANIES RECEIVE EASY ACCESS TO EVOTEC’S FULL RANGE OF PRE-CLINICAL AND CLINICAL DEVELOPMENT AND MANUFACTURING CAPABILITIES Hamburg, Germany, and Turin, […]
Newly launched TCR company ALKemist Bio announces a €6.9M Investment Round to develop first-in-class TCR Cell Therapy for ALK-Positive Tumors Turin, Italy […]
Claris Ventures appoints pharmaceutical industry veteran Michael Hodges as a Partner Claris Ventures appoints pharmaceutical industry veteran Michael Hodges as a Partner […]
Sibylla Biotech Raises €23 Million Series A to Advance Protein Degradation by Folding Interference Pipeline and Expand Technology Platform Sibylla Biotech Raises […]
Iama Therapeutics Raises €8 Million Series A IAMA THERAPEUTICS RACCOGLIE 8 MILIONI DI EURO PER LO SVILUPPO DI UN NUOVO CANDIDATO FARMACO […]
Heqet Therapeutics raises €8m to advance its RNA-based therapeutic program for cardiac regeneration March 23rd, 2022 – Heqet Therapeutics, a King’s College London […]
Kither Biotech Raises €18.5 Million Series B Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive […]
